S&P 500

7,580.07

-140.32

-1.82%

Dow 30

51,770.31

-572.25

-1.09%

Nasdaq

25,437.00

-747.73

-2.86%

Russell 2000

2,811.84

-47.37

-1.66%

10-Yr Bond

4.9290

-0.0600

-1.20%

VIX

19.42

+2.22

+12.91%

Gold

3,898.90

-132.50

-3.29%

Bitcoin USD

77,710.99

+591.55

+0.77%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

AstraZeneca Has an $80 Billion Dream and a Plan to Fix Its Stalling Stock

Mackenzie Tatananni

Fri, October 30, 2026 at 10:21 AM EDT 2 min read

AstraZeneca aims to free up funds to reinvest into its pipeline and meet its goal of $80 billion in annual revenue by 2030.

Terms and Privacy Policy

Your Privacy Choices

More Info

Mobilize your Website

View Site in Mobile | Classic

Share by:

U.S. markets closed

AstraZeneca Has an $80 Billion Dream and a Plan to Fix Its Stalling Stock

Recommended Stories

More News